Cargando…
Inulanolide A as a new dual inhibitor of NFAT1-MDM2 pathway for breast cancer therapy
The transcription factor NFAT1 and the oncogene MDM2 have crucial roles in breast cancer development, progression, and metastasis. We have recently discovered that NFAT1 activates MDM2 expression. Here, we identified a small molecule (named Inulanolide A) that dually inhibited both NFAT1 and MDM2 in...
Autores principales: | Qin, Jiang-Jiang, Wang, Wei, Sarkar, Sushanta, Voruganti, Sukesh, Agarwal, Rajesh, Zhang, Ruiwen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5078034/ https://www.ncbi.nlm.nih.gov/pubmed/27105525 http://dx.doi.org/10.18632/oncotarget.8873 |
Ejemplares similares
-
Identification of lineariifolianoid A as a novel dual NFAT1 and MDM2 inhibitor for human cancer therapy
por: Qin, Jiang-Jiang, et al.
Publicado: (2016) -
Inhibiting NFAT1 for breast cancer therapy: New insights into the mechanism of action of MDM2 inhibitor JapA
por: Qin, Jiang-Jiang, et al.
Publicado: (2015) -
Two Birds with One Stone: NFAT1-MDM2 Dual Inhibitors for Cancer Therapy †
por: Wang, Wei, et al.
Publicado: (2020) -
Identification of a new class of natural product MDM2 inhibitor: In vitro and in vivo anti-breast cancer activities and target validation
por: Qin, Jiang-Jiang, et al.
Publicado: (2014) -
Oral nano-delivery of anticancer ginsenoside 25-OCH(3)-PPD, a natural inhibitor of the MDM2 oncogene: Nanoparticle preparation, characterization, in vitro and in vivo anti-prostate cancer activity, and mechanisms of action
por: Voruganti, Sukesh, et al.
Publicado: (2015)